New to CUVITRU?
So what is a subcutaneous treatment anyway?
A subcutaneous immunoglobulin (SCIg) treatment is given under the skin, unlike an intravenous immunoglobulin (IVIg) treatment, which is given directly into a vein. CUVITRU is a subcutaneous treatment you can self-infuse at home, after appropriate training, using a needle and an infusion pump. CUVITRU can be administered in the abdomen, thighs, upper arms, and/or lower back.1
Unlike IVIg treatment, SCIg treatment administration parameters can be customized.1,4
Your doctor will determine how much medicine you need. Later, dosing will be adjusted based on how your body responds and your own individual administration preferences. With SCIg the frequency of infusions, the number of infusion sites, the infusion volume and rate can be customized.
After this initial period, if you and your doctor decide that self-administration at home is right for you, you will receive training from your doctor and can begin self-infusing when you’re both comfortable.
CUVITRU gives me the ability to talk to my doctor about changing my dosing schedule. So I can plan my treatment around my life, not the other way around.*1
For those switching from IVIg.1
When switching from an IVIg treatment to CUVITRU, your first infusion would begin 1 week after your last IVIg treatment. Your doctor will determine the initial weekly dose. After this initial period, you can work with your doctor to find the dosing schedule that best fits your needs and preferences—from daily to every 2 weeks.
After your healthcare team teaches you how, you can begin self-infusing at home, which some patients prefer.
With CUVITRU, my doctor and I can customize my treatment my way.1
*People who had previously received IVIg reported that CUVITRU fit better into their schedules and was more convenient than IV infusion.